SCHEMBL14508233

SCHEMBL14508233

CC1(C)c2cc(-c3ccc4c(c3)C(C)(C)c3cc(-c5cc(-c6ccccc6)ccc5-c5ccc6c(c5)C(C)(C)c5ccccc5-6)ccc3-4)ccc2-c2ccc(-c3ccccn3)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 10/20 0.51
TNKS O95271 2/20 0.37
GRM5 P41594 1/20 0.37
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
TP53 P04637 1/20 0.35
PKM P14618 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
KLF5 Q13887 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
CYP2A6 P11509 1/20 0.35
MEN1 O00255 1/20 0.35
APAF1 O14727 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14508216 1.00 PDK2 (0.51) PDK2TNKSGRM5LMNAMAPT
SCHEMBL14508156 0.96 PDK2 (0.54) PDK2TNKSLMNAKDM4ECTSD
SCHEMBL14508152 0.96 PDK2 (0.54) PDK2TNKSLMNAKDM4ECTSD
SCHEMBL14508194 0.96 PDK2 (0.54) PDK2TNKSLMNAKDM4ECTSD
SCHEMBL14508201 0.95 PDK2 (0.47) PDK2TNKSGRM5LMNAMAPT
SCHEMBL14508226 0.95 PDK2 (0.47) PDK2TNKSGRM5LMNAMAPT
SCHEMBL14508167 0.95 PDK2 (0.56) PDK2TNKSGRM5LMNAKDM4E
SCHEMBL14508137 0.94 PDK2 (0.46) PDK2GRM5LMNAMAPTRAB9A
SCHEMBL14508188 0.93 PDK2 (0.48) PDK2TNKSGRM5LMNAKDM4E
SCHEMBL14508211 0.93 PDK2 (0.51) PDK2TNKSGRM5LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed
US-20070122652-A1 Compound and organic electroluminescent device using same CANON KABUSHIKI KAISHA (JP) 2007-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070122652-A1 Compound and organic electroluminescent device using same OR10J3, LEF1, RPL19 PDK2 3230/4885TNKS 4442/4885GRM5 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.